I am a Senior Scientist at the UK Health Security Agency (UKHSA), specialising in the development and validation of immunological assays for vaccine evaluation and clinical trials. My work focuses on high-throughput pseudovirus neutralisation assays for emerging and high-consequence pathogens, including avian influenza, Nipah virus, and filoviruses, within regulated environments.
I completed my PhD in Infection and Immunity at the University of Edinburgh, where I used CRISPR–Cas9 screening and next-generation sequencing to study host–virus interactions.
I have expertise in molecular biology, assay development, and data analysis, and I am particularly interested in advancing scalable tools to support pandemic preparedness.
